Vir Biotechnology (NASDAQ:VIR) CAO Brent Sabatini Sells 1,530 Shares

robot
Abstract generation in progress

Vir Biotechnology’s CAO, Brent Sabatini, sold 1,530 shares of the company’s stock on February 13th at an average price of $7.79, reducing his stake by 3.10%. Following the sale, he directly owns 47,872 shares valued at approximately $372,923. The stock traded up 4.2% to $7.82 midday, with a mixed but predominantly positive analyst outlook and an average target price of $16.29.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)